Company News: Sanofi-Aventis, Chattem, Allergan and Pacific Communications

Share this article:
Sanofi-Aventis completed its acquisition of Chattem, strengthening its presence in the US consumer healthcare market and bolstering its OTC switch capabilities. Chattanooga, TN-based Chattem will continue to be led by Zan Guerry, CEO, who will report to Sanofi-Aventis US president and CEO Greg Irace.
 
Allergan
named Pacific Communications agency of record for overactive bladder treatment Sanctura XR. The review resulted from a co-promotion agreement Allergan entered into with Quintiles whereby Quintiles will leverage its expertise in primary care to rapidly deploy a specialized sales for ce for the product while Allergan continues to target urology. Pacific will act as agency of record on both efforts.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.